News 2013

Medigus Announces the Receipt of Approval from the Israeli Ministry of Health (MEA) for the Marketing of SRS™‏ Systems for the Treatment of Gastroesophageal Reflux Disease (GERD)

Israel - September 11, 2013

Medigus Announces the Receipt of Approval from the Israeli Ministry of Health (MEA) for the Marketing of SRS™‏ Systems for the Treatment of Gastroesophageal Reflux Disease (GERD). The receipt of approval is expected to expedite regulatory approvals in other countries, including approval from the regulatory authorities in China (SFDA)

Continue Reading

Medigus completed $8M private placement by OrbiMed

Medigus (TASE:MDGS) announces that it had closed an $8 million investment by OrbiMed Israel Partners LP. Upon the closing of the investment, Dr. Nissim Darvish, senior managing director at OrbiMed Israel, was appointed chairman of the board of directors of Medigus.

Continue Reading